3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
26
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Renal Insufficiency
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Radiosurgery
3
Androgen Antagonists
3
Prednisone
2
Docetaxel
2
Abiraterone Acetate
2
fludrocortisone acetate
1
enzalutamide
1
darolutamide
1
apalutamide
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Hydrocortisone
1
Gonadotropin-Releasing Hormone
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
gallium 68 PSMA-11
×
1 year
×
Clear all
No trials found.